Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial-Reference-Cited by-同舟云学术

Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial

Published:2019-02 Issue:10172 Volume:393 Page:678-688
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Herrlinger Ulrich,Tzaridis Theophilos,Mack Frederic,Steinbach Joachim Peter,Schlegel Uwe,Sabel Michael,Hau Peter,Kortmann Rolf-Dieter,Krex Dietmar,Grauer Oliver,Goldbrunner Roland,Schnell Oliver,Bähr Oliver,Uhl Martin,Seidel Clemens,Tabatabai Ghazaleh,Kowalski Thomas,Ringel Florian,Schmidt-Graf Friederike,Suchorska Bogdana,Brehmer Stefanie,Weyerbrock Astrid,Renovanz Miriam,Bullinger Lars,Galldiks Norbert,Vajkoczy Peter,Misch Martin,Vatter Hartmut,Stuplich Moritz,Schäfer Niklas,Kebir Sied,Weller Johannes,Schaub Christina,Stummer Walter,Tonn Jörg-Christian,Simon Matthias,Keil Vera C,Nelles Michael,Urbach Horst,Coenen Martin,Wick Wolfgang,Weller Michael,Fimmers Rolf,Schmid Matthias,Hattingen Elke,Pietsch Torsten,Coch Christoph,Glas Martin

Funder

German Federal Ministry of Education and Research

Publisher

Elsevier BV

Subject

General Medicine

Reference34 articles.

1. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma;Stupp;N Engl J Med,2005

2. Effect of tumor-treating fields plus maintenance temozolomide vs maintenance temozolomide alone on survival in patients with glioblastoma: a randomized clinical trial;Stupp;JAMA,2017

3. Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial;Gilbert;J Clin Oncol,2013

4. Phase II trial of temozolomide (TMZ) plus irinotecan (CPT–11) in adults with newly diagnosed glioblastoma multiforme before radiotherapy;Quinn;J Neuro–Oncol,2009

5. Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma;Chinot;N Engl J Med,2014

Cited by 404 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improving glioma drug delivery: A multifaceted approach for glioma drug development;Pharmacological Research;2024-10

2. Blood-tumor barrier in focus - investigation of glioblastoma-induced effects on the blood-brain barrier;Journal of Neuro-Oncology;2024-08-28

3. Glioblastoma in the real-world setting: patterns of care and outcome in the Austrian population;Journal of Neuro-Oncology;2024-08-27

4. Brain gliomas: Diagnostic and therapeutic issues and the prospects of drug-targeted nano-delivery technology;Pharmacological Research;2024-08

5. Current chemotherapy strategies for adults with IDH-wildtype glioblastoma;Frontiers in Oncology;2024-07-19